The establishment of PD-1 inhibitor treatment prognosis model based on dynamic changes of peripheral blood indexes in patients with advanced lung squamous cell carcinoma

BackgroundUnlike patients with lung adenocarcinoma, patients with lung squamous cell carcinoma (LUSC) do not derive significant benefits from targeted therapy. In recent years, immunotherapy has revolutionized the treatment approach for LUSC. However, not all patients with this type of cancer respon...

Full description

Saved in:
Bibliographic Details
Main Authors: Yuyan Xie, Hao Sun, Liying Shan, Xin Ma, Qingyu Sun, Fang Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-12-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2024.1454709/full
Tags: Add Tag
No Tags, Be the first to tag this record!